Latest News

Real-world fezolinetant (Veozah) sleep data help ob-gyns counsel patients hesitant about hormone therapy, according to Marla Shapiro, CM, MDCM.

Cultural upbringing gives context to sexual dysfunction but does not make the diagnosis, according to Sameena Rahman, MD, FACOG.

Experts address COVID-19 vaccine myths, safety evidence, and how to frame the benefits of vaccination in pregnancy.

Experts look ahead to new maternal vaccines and how to counsel patients on receiving several in one pregnancy.

In September, the FDA accepted an extended duration sNDA for the IUD with a decision expected in Q2 2027.

Experts discuss common patient concerns about vaccination in pregnancy and strategies to improve uptake.

ACOG issued its most comprehensive menopause guidance, grading treatments for VMS, sleep, and mood symptoms.

Experts discuss how obstetric and pediatric clinicians can coordinate to protect newborns.

Experts review ACOG's 2026-27 guidance and the RSV window extension for pregnant and postpartum patients.

On September 9, 2026, certolizumab pegol received FDA Breakthrough Therapy Designation for APS pregnancy; Jane E. Salmon, MD, reviews the IMPACT trial results behind it.

Psychotherapy addresses fear and anxiety that can blunt hormone and pelvic floor therapy in menopause care, according to Sheryl Kingsberg, PhD.

SUID was the largest single contributor to the Black-White infant mortality gap in 2024 and drove the biggest share of its rise since 2020.

Garima Sharma, MD, outlines validated cardiac risk scores for antenatal screening and the postpartum transitions needed to keep high-risk patients from being lost to follow-up.

Anti-CGRP antibody exposure in early pregnancy was linked to higher spontaneous abortion risk; propranolol was not.

In the debut episode of Missed & Dismissed, Calbeth C. Alaribe, DMSc, MPH, PA-C, CPCHE, talks with Charis Chambers, MD, about PCOS, the push to rename it PMOS, and why diagnostic delays so often begin in adolescence.

Get caught up with Contemporary OB/GYN! This list helps you navigate our top stories from the week, all in one place.

Pritelivir healed all HSV lesions by day 28 in 63% of immunocompromised adults vs 34% with comparators.

Fezolinetant (Veozah) was linked to objective and patient-reported sleep gains in OPTION-VMS, with no new safety signals observed.

HPV vaccination before pregnancy was linked to lower odds of preterm birth in a Swedish study of 624,713 births.

The prospective SOARA study will measure how often a 98%-specific ovarian cancer screening blood test leads to invasive procedures.

A new 3-part Lancet series reframes pregnancy as a cardiovascular risk window.

Wen Shen, MD, explains how clinicians can counter menopause misinformation from social media and steer patients toward evidence-based resources.

Wen Shen, MD, outlines when to treat perimenopausal symptoms and which history-taking red flags should prompt earlier bone and cardiovascular screening or referral.

Maternal high egg and peanut intake in pregnancy and lactation did not lower infant IgE-mediated egg or peanut allergy at 1 year in PrEggNut.

Missed the rollout of ACOG's 2026 Maternal Immunization Schedule? This FAQ breaks down everything clinicians need to know about the new guidance.

Jean Cunningham, PharmD, BCPS, explains how ob-gyns can link anxiety, sleep disruption, and cognitive changes to perimenopause—and catch it earlier.

The well-woman visit drives preventive care, but its structure leaves little room for the complexity of women's lives, according to Barbara Levy, MD.

A review finds post-miscarriage ultrasound heterogeneity is common and that symptoms, not endometrial thickness, should guide management after EPL.

Marla Shapiro, MDCM, explains how OPTION-VMS actigraphy data corroborated patient-reported sleep improvements with fezolinetant (Veozah) as early as week 4.

Wen Shen, MD, describes perimenopause as an opportunity for clinicians to revisit pregnancy-related risk factors and address cardiovascular health proactively.

A recap of the top videos and podcasts from Contemporary OB/GYN in September 2026, featuring expert interviews on salpingectomy, testosterone evidence, and more.